Medical Condition News

RSS

Artificial pancreas manages blood sugar levels in type 1 diabetes children

An artificial pancreas originally developed at the University of Virginia Center for Diabetes Technology safely and effectively manages blood sugar levels in children ages 6 to 13 with type 1 diabetes, a national clinical trial has found.

27 Aug 2020

Long-term brain monitoring technologies can benefit epilepsy patients

Today, the way a physician gets an idea of how many seizures a person with epilepsy has had is through the patient's own record of seizure activity in his day-to-day life.

27 Aug 2020

Human gut microbes play an important role in maintaining health

Bacteria and other microorganisms in the digestive tract are linked with dozens of health conditions including high blood pressure, high blood lipids, and body mass index (BMI) according to research presented today at ESC Congress 2020.

27 Aug 2020

Study highlights variable nutritional quality of plant foods

Vegetarian foods are not equally healthy, according to research presented today at ESC Congress 2020.

27 Aug 2020

Research identifies protein molecule that could be responsible for aggressive breast cancers

Groundbreaking cancer research by the University of South Australia has identified an invasive protein molecule that could be responsible for some of the most aggressive breast cancers.

27 Aug 2020

New discovery could help protect the liver from fructose-induced diseases

A team of international researchers including Monash University academics has discovered that, contrary to previous belief, fructose causes liver toxicity by changing the barrier function of the intestine.

27 Aug 2020

Young children’s early eating habits linked to later autistic-like personality traits

New research from Edith Cowan University has shown a link between young children’s early eating habits and higher levels of traits associated with autism as adults.

27 Aug 2020

AstraZeneca partners with World Heart Federation to reduce the global burden of heart failure

AstraZeneca today announced a new partnership with the leading voice in cardiovascular (CV) health, the World Heart Federation, to drive global action to prevent, control and reduce the burden of CV disease and its associated risks and complications.

From AstraZeneca 27 Aug 2020

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and achieved durable objective responses, or tumor shrinkage, in the majority of participants in the Phase I/II LIBRETTO-001 trial, according to researchers from The University of Texas MD Anderson Cancer Center.

27 Aug 2020

New approach to combination drug design could be applied to disease therapies beyond diabetes

Biomedical engineers at Duke University have shown that the efficacy of a two-pronged type 2 diabetes treatment increases when the drugs are linked by a heat-sensitive tether rather than simply concurrently administered.

27 Aug 2020

Study reveals neural mechanisms that contribute to fatigue in people with depression, MS, stroke

Scientists at Johns Hopkins Medicine using MRI scans and computer modeling say they have further pinpointed areas of the human brain that regulate efforts to deal with fatigue.

27 Aug 2020

Study: Blocking nerve signals to the pancreas could stop patients from developing type 1 diabetes

Your pancreas is a little sweet potato-shaped organ that sits snug behind your stomach. The pancreas is studded with islets, the cell clusters that house insulin-producing beta cells.

27 Aug 2020

Targeting a key gateway can help treat chronic pain, shows study

Something like a quarter of the world's population suffers from chronic pain at some point. As opposed to acute pain – for example, that feeling after hitting your finger with a hammer – chronic pain may not even have a clear cause, and it can linger for years or lifetimes.

27 Aug 2020

Obesity ups COVID-19 death risk by 48 percent

Now, a new study by researchers from the University of North Carolina (UNC), the World Bank, and Saudi Health Council, shows that obesity increases the risk of dying from COVID-19 by as much as 48 percent, hinting that a vaccine against the virus could be less effective in obese people.

26 Aug 2020

Blood test can help predict who is likely to develop psychotic disorders

Scientists have discovered that testing the levels of certain proteins in blood samples can predict whether a person at risk of psychosis is likely to develop a psychotic disorder years later.

26 Aug 2020

UMass Amherst researcher develops mHealth system to help stroke survivors in rehabilitation

A University of Massachusetts Amherst health informatician is developing a mobile health (mHealth) system, leveraging a wearable sensor that slips on a finger like a ring, to monitor and encourage movement and activity in the weak upper limb of stroke survivors.

26 Aug 2020

Novel cell-based therapy holds promise for obesity and diabetes

Obesity is the main cause of type 2 diabetes and related chronic illnesses that together will kill more people around the globe this year than the Covid-19 coronavirus.

26 Aug 2020

Scientists combine 3D bioprinting and computer modeling to study cancer metastasis in blood vessels

Lawrence Livermore National Laboratory scientists have paired 3D-printed, living human brain vasculature with advanced computational flow simulations to better understand tumor cell attachment to blood vessels, the first step in secondary tumor formation during cancer metastasis.

26 Aug 2020

UBC discovery may offer new treatment possibility for women with rare form of ovarian cancer

A recent finding by researchers at the BC Cancer Research Institute and the University of British Columbia may offer a new treatment possibility for people diagnosed with a rare and aggressive form of ovarian cancer.

26 Aug 2020

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.

26 Aug 2020

Medical Condition News

Artificial pancreas manages blood sugar levels in type 1 diabetes children

Long-term brain monitoring technologies can benefit epilepsy patients

Human gut microbes play an important role in maintaining health

Study highlights variable nutritional quality of plant foods

Research identifies protein molecule that could be responsible for aggressive breast cancers

New discovery could help protect the liver from fructose-induced diseases

Young children’s early eating habits linked to later autistic-like personality traits

AstraZeneca partners with World Heart Federation to reduce the global burden of heart failure

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

New approach to combination drug design could be applied to disease therapies beyond diabetes

Study reveals neural mechanisms that contribute to fatigue in people with depression, MS, stroke

Study: Blocking nerve signals to the pancreas could stop patients from developing type 1 diabetes

Targeting a key gateway can help treat chronic pain, shows study

Obesity ups COVID-19 death risk by 48 percent

Blood test can help predict who is likely to develop psychotic disorders

UMass Amherst researcher develops mHealth system to help stroke survivors in rehabilitation

Novel cell-based therapy holds promise for obesity and diabetes

Scientists combine 3D bioprinting and computer modeling to study cancer metastasis in blood vessels

UBC discovery may offer new treatment possibility for women with rare form of ovarian cancer

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News